Involvement of Th17 and Th1 effector responses in patients with hepatitis B

Journal of Clinical Immunology

Volumn 30, Issue 4, 2010, Pages 546-555

  Ye, Yufu ^a   Xie, Xiaojun ^a   Yu, Jiwei ^a   Zhou, Lin ^a   Xie, Haiyang ^a   Jiang, Guoping ^a   Yu, Xiaobo ^a   Zhang, Wenjin ^a   Wu, Jian ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Hepatitis B; IL 17; Interferon gamma; Regulatory T cells

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE; INTERLEUKIN 17; TRANSCRIPTION FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CELL DENSITY; CELL INFILTRATION; CHILD PUGH CLASS B; CHILD TURCOTTE PUGH SCORING SYSTEM; CLINICAL CLASSIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE EXPRESSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ABSCESS; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER HISTOLOGY; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION; ADULT; AGED; BIOSYNTHESIS; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; COMPLICATION; FEMALE; HELPER CELL; IMMUNOLOGY; LIVER; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HEPATITIS B; HUMANS; INTERLEUKIN-17; LIVER; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRANSCRIPTION FACTORS;

EID: 77956264119     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9416-3     Document Type: Article

References (36)

1. Bettelli E, Carrier YJ, Gao WD, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector T (H) 17 and regulatory T cells. Nature. 2006;441(7090):235-8.
2. Chisari FV, Hepatitis-B FC. Virus immunopathogenesis. Annu Rev Immunol. 1995;13:29-60.
3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29-60.
4. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147-63.
5. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117(3):645-52.
6. Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16(5-6): 541-51.
7. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology. 2007;47(4):598-607.
8. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123-32.
9. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26(8):912-9.
10. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485-517.
11. Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther. 1998;3 Suppl 3:13-24.
12. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347-52.
13. Lan R Y Z, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009;32(1):43-51.
14. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646-57.
15. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl): S13-21.
16. Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179-84.
17. Lohr HF, Weber W, Schlaak J, Goergen B, Zumbuschenfelde K H M, Gerken G. Proliferative response of CD4 (+) T-cells and hepatitis-B virus clearance in chronic hepatitis with or without hepatitis-B E-minus hepatitis-B virus mutants. Hepatology. 1995;22(1):61-8.
18. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl): S45-55.
19. Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol. 1999;162(11):6503-9.
20. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133-41.
21. Penna A, DelPrete G, Cavalli A, Bertoletti A, Delios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25(4):1022-7.
22. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5(3):215-29.
23. Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol. 2003;71(3):376-84.
24. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99(12):3025-33.
25. Steinman L. A brief history of T (H) 17, the first major revision in the T (H) 1/T (H) 2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139-45.
26. Takahashi H, Zeniya M, Watanabe F, Hayashi A, Hokari A, Aizawa Y, et al. Significance of intracellular Th1/Th2 cytokine analysis in chronic viral hepatitis. Hepatology. 1997;26(4):1926-6.
27. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113.
28. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251-76.
29. Vierling JM. The immunology of hepatitis B. Clin Liver Dis. 2007;11(4):727-59. vii-viii.
30. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369-80.
31. Xiao MJ, Wang CH, Zhang JH, Li ZG, Zhao XQ, Qin ZH. IFN gamma promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res. 2009;69(5):2010-7.
32. Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52-6.
33. Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37(4):248-54.
34. Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, et al. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol. 2008;15(12):3494-502.
35. Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50(5):980-9.
36. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4 (+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81-91.